United Therapeutics (UTHR) Tops Q4 EPS by 60c
Tweet
Share
E-mail
Get Alerts UTHR Hot Sheet
Price: $545.40 +0.24%
Revenue Growth %: +1.5%
Financial Fact:
Total revenues: 408.2M
Today's EPS Names:
CRMT, REPL, ANIX, More
Revenue Growth %: +1.5%
Financial Fact:
Total revenues: 408.2M
Today's EPS Names:
CRMT, REPL, ANIX, More
Join SI Premium – FREE
United Therapeutics (NASDAQ: UTHR) reported Q4 EPS of $7.70, $0.60 better than the analyst estimate of $7.10. Revenue for the quarter came in at $790.2 million versus the consensus estimate of $815.24 million.
For earnings history and earnings-related data on United Therapeutics (UTHR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Lennar Corp. (LEN) Misses Q2 EPS by 1c
- Explosions heard in Iran's Bandar Abbas; source unclear - Iran State Media cited by Reuters
- First Advantage to join S&P SmallCap 600, replacing Kennedy-Wilson
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
